2 Under-the-Radar Pharma M&A Targets for 2018 Post author:Sam Post published:January 10, 2018 Post category:BioPharma A look at why these two biopharma companies could have targets on their backs. Source: BioSpace You Might Also Like Shire to Consolidate 3,000+ Jobs Over 4 Years to 2 Massachusetts Sites June 29, 2017 Biogen Faces Biggest One-Day Drop March 16, 2017 FDA Green Lights AstraZeneca, Merck's Lynparza for Metastatic Breast Cancer January 11, 2018
